NDAORALSOLUTION
Approved
Nov 2021
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
20
Mechanism of Action
Cytochrome P450 3A4 Inducers
Clinical Trials (5)
Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine
Started Oct 2023
545 enrolled
Migraine
Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine
Started Feb 2019
777 enrolled
Migraine
The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users
Started Mar 2018
48 enrolled
MigraineMigraine;MenstrualContraception
A Study of Lasmiditan in Healthy Participants When Co-administered With Topiramate
Started Oct 2017
30 enrolled
Healthy
A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy
Started Oct 2014
63 enrolled
Epilepsy
Loss of Exclusivity
LOE Date
Aug 21, 2040
176 months away
Patent Expiry
Aug 21, 2040
Company
R-Pharm US
NJ - Princeton